Prescription Drug Information: Desvenlafaxine (Page 7 of 7)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL — 50 mg

NDC 68788-7194
Desvenlafaxine
Extended-Release Tablets
50 mg
PHARMACIST: Dispense the
accompanying Medication Guide
to each patient.
breckenridge A Towa Company

Repackaged By: Preferred Pharmaceuticals Inc.
Rx Only

Desvenlafaxine Extended-Release Tablets 50mg
(click image for full-size original)

DESVENLAFAXINE desvenlafaxine succinate tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68788-7194(NDC:51991-311)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DESVENLAFAXINE SUCCINATE (DESVENLAFAXINE) DESVENLAFAXINE 50 mg
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSE, UNSPECIFIED
MICROCRYSTALLINE CELLULOSE
POVIDONE K90
TALC
MAGNESIUM STEARATE
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 6000
FERRIC OXIDE RED
Product Characteristics
Color PINK (Light Pink) Score no score
Shape ROUND (Biconvex) Size 10mm
Flavor Imprint Code L349
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68788-7194-3 30 TABLET, EXTENDED RELEASE in 1 BOTTLE None
2 NDC:68788-7194-6 60 TABLET, EXTENDED RELEASE in 1 BOTTLE None
3 NDC:68788-7194-9 90 TABLET, EXTENDED RELEASE in 1 BOTTLE None
4 NDC:68788-7194-1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA204003 07/18/2018
Labeler — Preferred Pharmaceutical, Inc. (791119022)
Registrant — Preferred Pharmaceutical, Inc. (791119022)
Establishment
Name Address ID/FEI Operations
Preferred Pharmaceutical, Inc. 791119022 REPACK (68788-7194)

Revised: 05/2023 Preferred Pharmaceutical, Inc.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2024. All Rights Reserved.